• EZZ signs 3-year distribution agreement with ROFA Enterprises
• Minimum purchase value of A$21 million over the contract term
• ROFA to distribute EZZ-branded products in Thailand, Vietnam and Singapore

EZZ Life Science Holdings Limited (ASX: EZZ), a genomic life science company, has announced a new distribution agreement with ROFA Enterprises Pty Ltd (ROFA) for the sale of EZZ-branded products across key Southeast Asian markets. The three-year agreement commences in June 2025 and secures a minimum purchase value of A$21 million over the contract term. The agreement grants ROFA distribution rights for EZZ-branded products across Thailand, Vietnam, and Singapore. ROFA will be responsible for all local marketing, logistics and distribution costs in line with EZZ's operational standards. This new partnership aligns with EZZ's strategy to accelerate growth in key markets in Southeast Asia, which offer significant commercial upside and long-term growth potential due to rising health consciousness, expanding middle-class populations and increasing demand for high-quality genomic wellness and functional health products.

This new partnership with ROFA Enterprises is a major milestone in EZZ's regional expansion strategy, as the company looks to scale its brand footprint across the fast-growing Southeast Asian markets.